Makers Laboratories

What Makers Laboratories does

Makers Laboratories Limited is an Indian pharmaceutical company focused on branded generic formulations across general-health therapeutic segments including antibiotics, anti-malarials, cough and cold, cardio-diabetic, anti-allergic, anthelmintic, and neurotonic categories. The portfolio is organized under two umbrella brands — Inspira (retail packs for consumer-facing distribution) and Experia (bulk packs for dispensing pharmacies) — with established formulation brands such as Duramol (Paracetamol), Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin serving as the commercial anchors. Manufacturing is conducted at two facilities in the GIDC Industrial Estate, Naroda, Ahmedabad.

The company's business model is a classic Indian branded-generics play: it manufactures formulations, then distributes them through a multi-tier PAN India channel comprising 20 Consignment Agents, 15 Super Stockists, and over 1,500 Stockists, ultimately reaching 100,000 prescribing Doctors and 200,000 Retailers. Revenue is generated through one-time product sales to channel partners and downstream retailers, with no licensing, subscription, or recurring revenue mechanics indicated. The corporate office and registered office are located at Charkop, Kandivali (W), Mumbai.

Makers Laboratories Limited is a publicly listed company on Indian stock exchanges and is governed under SEBI regulations, with a 2022 Rights Issue on record. It holds a wholly-owned subsidiary named Resonance. The company has actively expanded into chronic-care categories (diabetes, hypertension) and emphasizes quality and affordability as its core value proposition. Multiple director resignations, including the February 2024 exit of the Company Secretary and Compliance Officer, are documented governance events that potential investors should weigh.

Name

Makers Laboratories

Legal name

Makers Laboratories Limited

Website

https://makerslabs.com

Company type

Public

Operating status

Operating

Headcount range

101–250 employees

Short description

Makers Laboratories Limited is an Indian publicly listed pharmaceutical company that manufactures and distributes branded generic formulations across antibiotics, anti-malarials, cough and cold, cardio-diabetic, and neurotonic categories, reaching 200,000 retailers and 100,000 doctors across India through a multi-tier distribution network.

Ownership category

akta.pro rank

Product category

Branded Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)

akta.pro secondary industries

Sterile Injectable Generics (HLAIABAC), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF)

Keywords

• Branded generic pharmaceuticals
• Pharmaceutical manufacturing
• General therapeutics
• Formulation products
• Affordable medicines

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Revenue generated from sale of branded generic pharmaceutical formulations covering wide range of General Health Therapeutic segments including antibiotics, cough & cold, cardio-diabetic, anti-allergic, anthelmintic, neurotonic, and other specialty medications.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels1 record

Core offering

Makers Laboratories Limited manufactures and sells branded generic pharmaceutical formulations across general health therapeutic segments including antibiotics, anti-malarials, analgesics, cough & cold remedies, cardio-diabetic, anti-allergic, anthelmintic, and neurotonic products. The company sells through two main product lines: Inspira (retail packs) and Experia (bulk packs/dispensing packs).

Product overview

Makers Laboratories Limited is an Indian pharmaceutical company focused on branded generics, offering two primary product lines: Inspira (retail packs) and Experia (bulk packs). The portfolio covers General Health Therapeutic segments including antibiotics (Exylin, Ciprolone), anti-malarials (Loroquin, Artemak-AB), analgesics (Duramol, Nimuwin), cough & cold remedies (Coffwin), anti-diabetics (Gli-me, Onlygliptin), cardiovascular medications (Cardical, Amator), and neurotonics (Gabamak). Top formulation brands include Duramol (Paracetamol), Artemak-AB (Arteether), Loroquin (Chloroquine), Nimuwin (Nimeselide), Coffwin, and Exylin. The company has also launched new diabetic and hypertensive drug ranges including Voglibose, Gli-me (Glimepiride + Metformin + Pioglitazone), and Hypernorm (Telmisartan). Distribution operates PAN India through 20 Consignment Agents and 15 Super Stockiest, reaching over 1500 Stockiest, 100,000 Doctors, and 200,000 Retailers.

Differentiator

Problem solved

Functional benefit

Brands

• Inspira: Retail packs product brand covering a wide range of therapeutic segments including antibiotics, anti-diabetics, anti-hypertensives, cough & cold, digestives, neurotonics, and nutritional supplements.
• Experia

Products and services

• Inspira - Retail Packs Retail pack pharmaceutical products covering multiple therapeutic segments including antibiotics, anti-inflammatory, anti-diabetics, cardiovascular medications, cough & cold, digestives, neurotonics, and nutritional supplements for consumer-facing retail distribution through pharmacies and retail chemists across India.
• Experia - Bulk Packs Bulk pack pharmaceutical products for dispensing/pharmacy distribution including generic formulations like Amoxycillin, Cetirizine, Ciprofloxacin, Paracetamol, and other essential medicines packaged for bulk/Institutional dispensing channels.
• Duramol (Paracetamol) Paracetamol-based analgesic brand and top formulation product of Makers Laboratories for treatment of headache and high fever, available as tablets and other formulations.
• Artemak-AB (α-β Arteether) Arteether-based anti-malarial injection brand used for treatment of severe and complicated malaria including cerebral malaria.
• Loroquin (Chloroquine) Chloroquine phosphate-based anti-malarial brand for effective treatment of malaria, including Loroquine-250 tablets.
• Nimuwin (Nimuselide) Nimesulide-based anti-inflammatory analgesic brand for arthritis, musculoskeletal disorders, and pain management.
• Coffwin (Anti-Cough Range) Cough and cold control product range including syrups for dry, whooping, and chronic cough treatment, covering COFFWIN-DXP syrup and COFFWIN syrup.
• Exylin (Amoxycillin Range) Amoxycillin-based antibiotic brand covering dispersible tablets, capsules, and dry syrup formulations for respiratory and other infections, including Exylin-250 dispersible tablets and EXYLIN CLV KID dry syrup.
• Gli-me Range (Glimepiride + Metformin + Pioglitazone) Fixed-dose combination anti-diabetic range for diabetes management combining glimepiride, metformin, and pioglitazone.
• Hypernorm Range (Telmisartan) Anti-hypertensive range featuring telmisartan for blood pressure management.
• Voglibose Anti-diabetic medication for type 2 diabetes management.

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Cipla: Large Indian pharma incumbent with broad respiratory, anti-infective, and chronic-care portfolios; a relevant incumbent benchmark given overlap with Coffwin, Exylin, and the new chronic-care launches.
• Mankind Pharma: India's largest domestic pharma company by volume, with similar affordable-generics positioning and PAN India distribution; represents the dominant competitive benchmark in this category.
• Torrent Pharmaceuticals: Major Indian branded-generics player with strong chronic-care (cardio-diabetic) presence, directly relevant as Makers Labs expands Gli-me, Hypernorm, and Onlygliptin.

Direct peers

• JB Chemicals & Pharmaceuticals: Indian branded-generics player with overlapping therapeutic focus in anti-infectives, gastro, and cardio-diabetics, and a similar strategy of brand-building through a strong field force.
• Ipca Laboratories: Indian branded-generics company with strong positions in anti-malarials, anti-infectives, and pain management — directly comparable to Makers Labs' Loroquin, Exylin, and Duramol franchises.
• Ajanta Pharma: India-focused branded-generics company with overlap in anti-infectives, anti-malarials, cardiology, and dermatology, targeting similar doctor/retailer channels.
• Alkem Laboratories: Among India's largest branded-generics companies with comparable therapy breadth (anti-infectives, cough & cold, neuro, cardio-diabetic) and PAN India distribution; a relevant size-up peer for Makers Labs.
• Unichem Laboratories: Indian branded-generics player with therapeutic overlap in anti-infectives, cardio, and CNS, pursuing similar hospital and retail prescription channels in India.
• Lincoln Pharmaceuticals: Smaller India-listed branded-generics company with overlapping anti-infective, anti-malarial, and cough/cold offerings and a comparable domestic distribution model — a useful size-equivalent peer.
• FDC Limited: Indian branded-generics and formulations company with a comparable mix of anti-infectives, cough & cold, and ophthalmic/ENT products, operating a similar multi-tier domestic distribution model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/makers-laboratories-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Makers Laboratories